Literature DB >> 1515578

CaBP D-28k and NADPH-diaphorase coexistence in the magnocellular neurosecretory nuclei.

J R Alonso1, F Sánchez, R Arévalo, J Carretero, J Aijón, R Vázquez.   

Abstract

Coexistence of the calcium binding protein calbindin D-28k and NADPH-diaphorase activity was studied in the magnocellular secretory nuclei of the rat hypothalamus using both immunocytochemical and histochemical techniques. Coexistence was found in all the nuclei considered (supraoptic, paraventricular, circularis and fornicals nuclei) with the exception of the hypothalamic area situated between the supraoptic and the paraventricular nuclei. Since both stainings are reliable markers, not based upon the physiological characteristics at a given moment, our study provides a further characterization of the neurons in the magnocellular neurosecretory nuclei.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515578     DOI: 10.1097/00001756-199203000-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Heterogeneity in calbindin-D28k expression in oxytocin-containing magnocellular neurons of the rat hypothalamus.

Authors:  R Arai; D M Jacobowitz; S Deura
Journal:  Histochemistry       Date:  1994-01

Review 2.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

3.  Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat.

Authors:  F Sánchez; J R Alonso; R Arévalo; E Blanco; J Aijón; R Vázquez
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

Review 4.  Mouse models of growth hormone deficiency.

Authors:  Edward O List; Reetobrata Basu; Silvana Duran-Ortiz; Jackson Krejsa; Elizabeth A Jensen
Journal:  Rev Endocr Metab Disord       Date:  2020-10-09       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.